Skip to content

Clinical trials

Completed Phase 1/2 Triple Negative Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Phase: Phase 1/2 Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20122
20141
20153
20167
20179
20183
20197
20202
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cantargia AB2
Incyte Biosciences International Sàrl2
Novartis Pharmaceuticals2
TransThera Sciences (Nanjing), Inc.2
Alliance for Clinical Trials in Oncology1
BeiGene1
BioAtla, Inc.1
Bristol-Myers Squibb1
City of Hope Medical Center1
Corcept Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms40
Breast Neoplasms20
Ovarian Neoplasms10
Small Cell Lung Carcinoma10
Carcinoma, Non-Small-Cell Lung9
Endometrial Neoplasms7
Melanoma7
Pancreatic Neoplasms7
Neoplasms6
Stomach Neoplasms6

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.